Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT04610918 |
| Other study ID # |
1000069821 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
October 20, 2020 |
| Est. completion date |
December 31, 2022 |
Study information
| Verified date |
February 2023 |
| Source |
The Hospital for Sick Children |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
Background: Improvement in clinical care has resulted in longer life expectancy of children
with intestinal failure (IF). However, recent data indicate that their body composition (BC)
is abnormal with a relatively high fat mass (FM) and low fat free mass (FFM). Abnormal BC is
linked to poor prognosis and increased length of hospital stay; yet BC is not assessed in
pediatric clinical practice. Instead, growth charts which lack sensitivity to detect changes
in BC are used. Physical activity (PA) is the most important predictor of FFM and increased
PA contributes to decreased FM. Decreased PA in childhood is associated with increased FM and
decreased FFM which are linked to diabetes and cardiovascular disease in adulthood.
Dual-energy X-ray Absorptiometry (DXA) is considered the reference method for measuring BC in
the clinical setting but it is expensive and not suitable for routine use. Bioelectrical
Impedance Analysis (BIA) on the other hand is relatively inexpensive and non-invasive but
needs to be validated for use in patients with IF. Objectives: 1) validate BIA against DXA as
a clinical tool for monitoring changes in BC in children with IF, 2) quantify PA levels using
activity counts from accelerometers and 3) assess strength. Design: 1-18 years, with IF
followed by the intestinal rehabilitation program at SickKids. All subjects receiving a DXA
for routine clinical monitoring are eligible. BIA and muscle strength will be measured in
clinic. Demographic data and IF related factors including height, weight, PN prescription,
age, diagnosis, bowel length and length of time off PN for those who have achieved enteral
autonomy will be obtained. DXA measurement will be done by Diagnostic Imaging at SickKids.
Patients will be fitted with an accelerometer to be worn for 7 days. Statistics: Differences
between sexes will be assessed by t test. Relationship between PA and BC, and BC and muscular
strength will be assessed by linear regression analysis. Agreement between DXA and BIA will
be assessed using a Bland-Altman test. Significance will be set at p<0.05. Significance: This
study has the potential to establish BIA as a convenient clinical tool to assess BC and
provide a more accurate basis for nutritional and PA prescriptions to optimize long-term
outcomes and quality of life in IF patients.
Description:
METHODOLOGY:
Subjects:
Participants with IF will be recruited from patients followed by our multidisciplinary
intestinal rehabilitation program at SickKids.
Exclusion criteria: patients who are wheelchair bound or non-weight bearing, those unwilling
to participate.
Methods:
An annual DXA is ordered for all our patients beginning at 1-year of age as part of routine
clinical monitoring. On the day of the scheduled DXA, FFM using BIA, FM using Skinfolds and
muscle strength will be measured in clinic. After DXA measurement, patients will be fitted
with an accelerometer to be worn for 7 days.
Body composition: 3 methods - BIA, Skinfolds & DXA
Whole body and segmental BIA (leg, trunk and arm) will be taken on the right side of the body
using a fixed frequency analyzer (50kHz) (BIA model 101A: RJL Systems). Resistance (R) and
reactance (Xc) measurements will be made using 4-terminal bioelectrical impedance analyzer
according to the manufacturer's recommendations after 10 hour overnight fasting for patients
on enteral nutrition. Three readings R and Xc (in) will be taken from each subject. Patients
on parenteral nutrition (PN) will be prescribed a standard fluid intake of 130 mls/kg and be
cycled off PN for 3 hrs before measurement of BC. Body composition will also be assessed by
BIA in clinic and DXA (GE-Lunar DPS Pro (EG Healthcare, Waukesha, WI, USA), at the Radiology
Department, SickKids as part of routine annual clinical monitoring.
Four SF thicknesses (triceps, biceps, subscapular, and super iliac) will measured to the
nearest 1mm with a Harpenden caliper to obtain estimates of fat mass.
Anthropometric & IF related factors: Data will be collected on PN prescription, % of calories
on PN and enteral nutrition, number of months weaned of PN (if off PN), age, sex, diagnosis,
weight and height.
Physical activity level:
Physical activity will be measured by accelerometry using the Actigraph GT3X accelerometer
for measuring activity counts. It provides quantitative information regarding vertical
acceleration of the trunk, and lower body parts at specified time intervals and can be used
to evaluate frequency, intensity and duration of PA. Their small size and robust design make
them an excellent alternative for use in children. They are less burdensome relative to heart
rate monitors and capable of detecting the intermittent activity patterns characteristic of
children.
Participants will be asked to wear the accelerometer for 7 consecutive days, including two
weekend days during waking hours except when participating in water related activities (e.g.,
showering, swimming). The accelerometer will be worn on an elastic belt on the right hip,
above the iliac crest. Each subject will receive a call by a research coordinator to remind
them to wear the monitor. Subjects will also be given a handout that will include common
solutions to potential barriers for wearing the monitor along with a prepaid envelope to
return the accelerometer at the completion of the 7 days. Data from the accelerometers will
be downloaded and analyzed with the manufacturer's software.
Muscle strength
In this study, objective measures will be used to assess both functional strength and
specific muscle strength of the participants. The Bruininks-Oseretsky Test of Motor
Proficiency-2 (BOT-2) is norm referenced and designed to measure gross and fine motor skills
in children and youth 4-21 years of age. It is a widely accepted test with a reliable and
efficient measure of motor proficiency. The strength subtest will be utilized in this study
and is designed to measure functional strength. Children will be tested on their grip
strength using a Jamar 5030J1 dynamometer. Specific muscle strength of select arm and leg
muscles will also be measured clinically by a physiotherapist.
Subjects:
Patient with intestinal failure:
Patients with IF will undergo all tests as described above. Before clinic visit, patients
will be contacted by the person preparing for clinic (a study team member) and the study will
be introduced to the parents or child by a member of the health care team. If parents are
interested, the study will be further explained in clinic and any questions answered by a
study team member. The same person will obtain informed consent/assent (study team member but
not a member of the health care team) Patients will be recruited in clinic.
All patients with IF followed by the GIFT team at the hospital and aged 1-18 years will be
eligible to participate except those who are wheel chair bound.
Control participants:
Healthy control participants will be recruited by posting flyers in common areas at the
Hospital for Sick Children and the PGCRL. Contact information for the study team member
accepting enquire will be included on the flyer. These postings will be negotiated through
Public Affairs. Healthy controls will also be recruited through families of patients with IF
and children of staff members and other colleagues at the Hospital for Sick Children. Two
healthy controls will be recruited for each case.
Healthy controls will be age, race and sex matched. Age will be matched within ±2 months for
subjects between 1-3 years and within ±6 month for those 4 years and above.
Both IF patents and controls will be fitted with an accelerometer and sent home to wear it
for 7 days. A stamped and addressed envelope will be given to mail the accelerometer back to
the hospital for those patient who live outside of the GTA. For those residing within the
GTA, the accelerometers will be picked up from their homes or an arranged location by study
team members.
